Cite
HARVARD Citation
Ali, S. et al. (2016). Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. Oncologist. pp. 762-770. [Online].